| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-09-17 15:38 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,386
+540 vol $4.42 each |
175,556 | |
| Filed 2025-09-17 15:36 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,006
+940 vol $6.39 each |
175,016 | |
| Filed 2025-07-11 16:30 Tx date 2025-04-03 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-649,088.10
-83,970 vol $7.73 each |
736,536 | |
| Filed 2025-06-18 16:21 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,730
+555 vol $4.92 each |
174,076 | |
| Filed 2025-06-18 16:19 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,952
+1,151 vol $6.04 each |
173,521 | |
| Filed 2025-04-04 18:40 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$66,531
+10,783 vol $6.17 each |
172,370 | |
| Filed 2025-04-04 18:37 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-96,249.54
-18,474 vol $5.21 each |
129,802 | |
| Filed 2025-04-04 18:34 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-48,124.77
-9,237 vol $5.21 each |
11,652 | |
| Filed 2025-03-29 16:18 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$325,112
+52,353 vol $6.21 each |
148,276 | |
| Filed 2025-03-29 16:17 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$997,040
+160,554 vol $6.21 each |
820,506 | |
| Filed 2025-03-20 15:25 Tx date 2025-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,222
+441 vol $5.04 each |
161,587 | |
| Filed 2025-03-20 15:23 Tx date 2025-03-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,698
+953 vol $5.98 each |
161,146 | |
| Filed 2024-12-18 08:26 Tx date 2024-12-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,887
+3,032 vol $5.24 each |
160,193 | |
| Filed 2024-09-18 09:59 Tx date 2024-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,223
+395 vol $5.63 each |
157,161 | |
| Filed 2024-09-18 09:59 Tx date 2024-09-15 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,392
+1,931 vol $5.90 each |
156,766 | |
| Filed 2024-08-19 13:56 Tx date 2024-08-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,919
-5,000 vol $5.78 each |
154,835 | |
| Filed 2024-08-19 13:55 Tx date 2024-08-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,000
+5,000 vol $5.20 each |
159,835 | |
| Filed 2024-08-19 13:54 Tx date 2024-08-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-26,000
-5,000 vol $5.20 each |
659,952 | |
| Filed 2024-08-19 13:53 Tx date 2024-08-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-21,320
-4,100 vol $5.20 each |
664,952 | |
| Filed 2024-08-19 13:51 Tx date 2024-08-19 |
$GUD
Knight Therapeutics Inc. |
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,288
-4,100 vol $5.68 each |
154,835 |